Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies.

Rheumatology (Oxford) · 2026 · PMC13070709 · PMID 41872012

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approached significanceno p-value reported

The association persisted after further adjustment for other extramuscular and muscular disease activity but was no longer significant when skeletal disease activity was adjusted for cutaneous disease, though it approached significance.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.